Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Surgery Partners, Inc. (SGRY) trades at a P/S ratio of 0.9×. Over the past ten years it has ranged from 0.1× (March 2020) to 2.4× (April 2022); the current reading is higher than 59% of that period. That is below the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.6× (30.71%)
FY2024 0.9× (40.81%)
FY2023 1.4× 52.07%
FY2022 1.0× (45.22%)
FY2021 1.7× 128.54%
FY2020 0.8× 84.28%
FY2019 0.4× 55.54%
FY2018 0.3× (44.82%)
FY2017 0.5× (25.98%)
FY2016 0.6× (15.60%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 0.6× 40.49%
Mar 2026 0.5× (22.96%)
Dec 2025 0.6× (29.05%)
Sep 2025 0.8× (3.99%)
42 more quarters

Against its own ten years

Low 0.1× High 2.4×
Ten-year median 0.8×
Current reading's percentile 58

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on SGRY